These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23038002)
1. Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models. Miyashita T; Toyoda Y; Tsuneyama K; Fukami T; Nakajima M; Yokoi T J Toxicol Sci; 2012; 37(5):931-42. PubMed ID: 23038002 [TBL] [Abstract][Full Text] [Related]
2. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. Luo L; Fang K; Dan X; Gu M Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat. Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202 [TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867 [TBL] [Abstract][Full Text] [Related]
13. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα). Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374 [TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
17. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310 [TBL] [Abstract][Full Text] [Related]
18. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice. Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068 [TBL] [Abstract][Full Text] [Related]
19. Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. Li H; Yoo W; Park HM; Lim SY; Shin DH; Kim S; Park HY; Jeong TS Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083413 [TBL] [Abstract][Full Text] [Related]
20. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]